Möchten Sie immer auf dem neuesten Stand bleiben?

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th - Mar 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. ...

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Advanced Pharmacovigilance: From Performing Successful Due Diligence to Benefit-Risk Assessments - What to Consider Training Course (Mar 23rd - Mar...

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Training Course (Mar 5th - Mar 6th, 2026)" training has been added to ...

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "A Practical Guide to Writing Risk Management Plans (RMPs) Training Course (Mar 20, 2026)" training has been added to ResearchAndMarkets.com's...

SAN FRANCISCO and BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- SandboxAQ and MapLight Therapeutics, Inc. (Nasdaq: MPLT) announced today that the companies have entered into a strategic collaboration to...

FDA Commissioner Marty Makary, North Carolina Governor Josh Stein and Novartis leadership highlight importance of new hub to US patients and local economyConstruction reflects company’s commitment to...

Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ...

Autobahn Labs and Astellas form a strategic partnership to source and develop early-stage drug discovery programs from academia.

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "China's Licensing Trends Shaping Global Drug Development" report has been added to ResearchAndMarkets.com's offering.Over the past five years, China's...

Larkspur Biosciences announced the first participant has been dosed in the Phase 1 clinical study of its lead candidate, LRK-4189, in healthy volunteers.